Share-based Payment Arrangement, Expense of Third Harmonic Bio, Inc. from 30 Sep 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Third Harmonic Bio, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2021 to 31 Mar 2025.
  • Third Harmonic Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $3,270,000, a 47% increase year-over-year.
  • Third Harmonic Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2025 was $12,133,000, a 33% increase year-over-year.
  • Third Harmonic Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $11,086,000, a 16% increase from 2023.
  • Third Harmonic Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $9,577,000, a 102% increase from 2022.
  • Third Harmonic Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4,751,000, a 832% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Third Harmonic Bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $12,133,000 $3,270,000 +$1,047,000 +47% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $11,086,000 $3,193,000 +$1,434,000 +82% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $9,652,000 $3,062,000 +$771,000 +34% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $8,881,000 $2,608,000 -$237,000 -8.3% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $9,118,000 $2,223,000 -$459,000 -17% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $9,577,000 $1,759,000 -$377,000 -18% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $9,954,000 $2,291,000 +$1,285,000 +128% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $8,669,000 $2,845,000 +$1,686,000 +145% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $6,983,000 $2,682,000 +$2,232,000 +496% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $4,751,000 $2,136,000 01 Oct 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $1,006,000 +$869,000 +634% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $1,159,000 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $450,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q3 2021 $137,000 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3

Third Harmonic Bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $11,086,000 +$1,509,000 +16% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $9,577,000 +$4,826,000 +102% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $4,751,000 +$4,241,000 +832% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $510,000 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.